Cargando…

miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer

BACKGROUND: Bladder cancer is the most common urinary system malignancy in the United States and is characterized by its diverse prognosis and high recurrence rate. However, the molecular mechanisms underlying its progression remain unknown. Accumulating evidence suggests a critical role for miRNAs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kai, Lü, Hang, Qu, Hongchen, Xie, Qingpeng, Sun, Tao, Gan, Ou, Hu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935362/ https://www.ncbi.nlm.nih.gov/pubmed/31920334 http://dx.doi.org/10.2147/OTT.S223448

Ejemplares similares

MiR-492 impairs the angiogenic potential of endothelial cells
por: Patella, Francesca, et al.
Publicado: (2013)

Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer
por: Kupcinskas, Juozas, et al.
Publicado: (2014)

hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492
por: Feng, Zhenzhen, et al.
Publicado: (2023)

Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro
por: Liu, Mei, et al.
Publicado: (2018)

Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway
por: Huang, Yan, et al.
Publicado: (2018)

Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axis
por: Chang, Yue, et al.
Publicado: (2021)

Circular RNA hsa_circ_0072309 inhibits proliferation and invasion of breast cancer cells via targeting miR-492
por: Yan, Lin, et al.
Publicado: (2019)

miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer
por: Wu, Shuai, et al.
Publicado: (2020)

Ultrasound-targeted microbubble destruction mediated miR-492 inhibitor suppresses the tumorigenesis in non-small cell lung cancer
por: Zou, Wendi, et al.
Publicado: (2021)

CircFBXW7 Inhibits Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer Cells by Regulating miR-492
por: Zhu, Shen-Yu, et al.
Publicado: (2022)

Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium
por: Naser Al Deen, Nataly, et al.
Publicado: (2022)

MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN
por: Jiang, Jianxin, et al.
Publicado: (2014)

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015)

Association between miR-492 rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children
por: Zheng, Yi, et al.
Publicado: (2020)

MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A
por: Yuan, Daozhang, et al.
Publicado: (2017)

Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer
por: Lin, Hao, et al.
Publicado: (2021)

MiR-326: Promising Biomarker for Cancer
por: Pan, Yao-Jie, et al.
Publicado: (2019)

The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492
por: Zhu, Linwen, et al.
Publicado: (2022)

Whole-Genome Sequence of the Microcin E492-Producing Strain Klebsiella pneumoniae RYC492
por: Marcoleta, Andrés, et al.
Publicado: (2013)

Evaluation of miR‐130 family members as circulating biomarkers for the diagnosis of bladder cancer
por: Wang, Jingyao, et al.
Publicado: (2020)

Evaluation of miR-711 as Novel Biomarker in Prostate Cancer Progression
por: Waseem, Mohammad, et al.
Publicado: (2017)

Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection
por: Li, Bo-sheng, et al.
Publicado: (2012)

Exosomal miR-93-5p as an important driver of bladder cancer progression
por: Yuan, Feng, et al.
Publicado: (2023)

Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells
por: Xiang, Min, et al.
Publicado: (2019)

Circular RNA hsa_circ_0005567 overexpression promotes M2 type macrophage polarization through miR-492/SOCS2 axis to inhibit osteoarthritis progression
por: Zhang, Jinling, et al.
Publicado: (2021)

Allele-Specific Impairment of GJB2 Expression by GJB6 Deletion del(GJB6-D13S1854)
por: Rodriguez-Paris, Juan, et al.
Publicado: (2011)

miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells
por: Li, Jing, et al.
Publicado: (2016)

Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis
por: Wang, Jingyao, et al.
Publicado: (2021)

The immunogenic involvement of miRNA-492 in mycoplasma pneumoniae infection in pediatric patients
por: Jia, Zhiyi, et al.
Publicado: (2022)

Circ-ZFR Promotes Progression of Bladder Cancer by Upregulating WNT5A Via Sponging miR-545 and miR-1270
por: Luo, Liping, et al.
Publicado: (2021)

MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1
por: Yao, Kun, et al.
Publicado: (2015)

Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer
por: Mahdavinezhad, Ali, et al.
Publicado: (2015)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2017)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2022)

Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation
por: Yang, Chen, et al.
Publicado: (2021)

miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019)

miR-196, an Emerging Cancer Biomarker for Digestive Tract Cancers
por: Lu, Ya-Ching, et al.
Publicado: (2016)

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Circ_0002623 promotes bladder cancer progression by regulating the miR‐1276/SMAD2 axis
por: Zhang, Zhaocun, et al.
Publicado: (2022)

LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p
por: Han, Xiancheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ostpq0mvq1cbrpogolqjkklb82